|4Jun 13, 4:42 PM ET

Al-Marzooqi Fahed 4

4 · vTv Therapeutics Inc. · Filed Jun 13, 2024

Insider Transaction Report

Form 4
Period: 2024-02-27
Transactions
  • Award

    Director stock option (right to buy)

    2024-02-27$11.81/sh+4,055$47,8906,555 total
    Exercise: $11.81Exp: 2034-02-27Class A Common Stock (4,055 underlying)
Footnotes (1)
  • [F1]The option vests in quarterly equal installments over the three year period beginning on February 27, 2024. The option was conditioned upon shareholder approval of the 2024 Equity Incentive Plan, which was approved by the shareholders on June 11, 2024.

Documents

1 file
  • 4
    wk-form4_1718311314.xmlPrimary

    FORM 4